No. |
Variant name |
Chromosome position |
Chromatin state |
Related regulatory elements |
Target genes |
Extended variants |
Associated traits |
1 |
rs9309195 |
chr2:50992027-50992028 |
Weak transcription Enhancers
|
n/a
|
n/a
|
LD-proxies of rSNPOverlapped rCNV
|
mRNA abundance
|
2 |
rs145479318 |
chr2:50992043-50992044 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
3 |
rs373497095 |
chr2:50992057-50992058 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
4 |
rs9309196 |
chr2:50992109-50992110 |
Weak transcription Enhancers
|
n/a
|
n/a
|
LD-proxies of rSNPOverlapped rCNV
|
mRNA abundance
|
5 |
rs557795455 |
chr2:50992111-50992112 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
6 |
rs562575205 |
chr2:50992116-50992117 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
7 |
rs371155879 |
chr2:50992128-50992129 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
8 |
rs374886582 |
chr2:50992135-50992136 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
9 |
rs377321895 |
chr2:50992153-50992154 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
10 |
rs558653441 |
chr2:50992164-50992165 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
11 |
rs556655929 |
chr2:50992196-50992197 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
12 |
rs576600544 |
chr2:50992197-50992198 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
13 |
rs531396827 |
chr2:50992223-50992224 |
Enhancers Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
14 |
rs534521740 |
chr2:50992244-50992245 |
Enhancers Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
15 |
rs191461396 |
chr2:50992295-50992296 |
Enhancers Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
16 |
rs574393443 |
chr2:50992296-50992297 |
Enhancers Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
17 |
rs370804015 |
chr2:50992307-50992308 |
Enhancers Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
18 |
rs182853678 |
chr2:50992313-50992314 |
Enhancers Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
19 |
rs575224439 |
chr2:50992345-50992346 |
Enhancers Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
20 |
rs545553105 |
chr2:50992348-50992349 |
Enhancers Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
21 |
rs147689502 |
chr2:50992351-50992352 |
Enhancers Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
22 |
rs571468346 |
chr2:50992428-50992429 |
Enhancers Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
23 |
rs532714957 |
chr2:50992439-50992440 |
Enhancers Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
24 |
rs188175968 |
chr2:50992521-50992522 |
Enhancers Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
25 |
rs142553629 |
chr2:50992530-50992531 |
Enhancers Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
26 |
rs192968588 |
chr2:50992559-50992560 |
Enhancers Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
27 |
rs548895866 |
chr2:50992588-50992589 |
Enhancers Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
28 |
rs182853375 |
chr2:50992629-50992630 |
Enhancers Flanking Active TSS Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
29 |
rs10176529 |
chr2:50992650-50992651 |
Enhancers Flanking Active TSS Weak transcription
|
n/a
|
n/a
|
LD-proxies of rSNPOverlapped rCNV
|
mRNA abundance
|
30 |
rs552218762 |
chr2:50992663-50992664 |
Enhancers Flanking Active TSS Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
31 |
rs368470641 |
chr2:50992776-50992777 |
Enhancers Flanking Active TSS Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
32 |
rs187933007 |
chr2:50992778-50992779 |
Enhancers Flanking Active TSS Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
33 |
rs76159848 |
chr2:50992829-50992830 |
Enhancers Weak transcription Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
34 |
rs552744622 |
chr2:50992830-50992831 |
Enhancers Weak transcription Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
35 |
rs114290796 |
chr2:50992882-50992883 |
Enhancers Weak transcription Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
36 |
rs3914723 |
chr2:50992927-50992928 |
Enhancers Weak transcription Flanking Active TSS
|
n/a
|
n/a
|
LD-proxies of rSNPOverlapped rCNV
|
n/a
|
37 |
rs549722481 |
chr2:50992962-50992963 |
Enhancers Weak transcription Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
38 |
rs529303444 |
chr2:50992969-50992970 |
Enhancers Weak transcription Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
39 |
rs575097233 |
chr2:50993011-50993012 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
40 |
rs192302900 |
chr2:50993014-50993015 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
41 |
rs3914724 |
chr2:50993048-50993049 |
Weak transcription Enhancers
|
n/a
|
n/a
|
LD-proxies of rSNPOverlapped rCNV
|
n/a
|
42 |
rs183639819 |
chr2:50993061-50993062 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
43 |
rs146710943 |
chr2:50993064-50993065 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
44 |
rs559969100 |
chr2:50993084-50993085 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
45 |
rs116280866 |
chr2:50993100-50993101 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
46 |
rs542126701 |
chr2:50993104-50993105 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
47 |
rs564022177 |
chr2:50993168-50993169 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
48 |
rs530771900 |
chr2:50993199-50993200 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
49 |
rs539167776 |
chr2:50993326-50993327 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
50 |
rs552155514 |
chr2:50993387-50993388 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|